Navigation Links
Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
Date:8/29/2007

otinic alpha-7 receptor collaboration with Roche. Under the terms of the Company's agreement with Roche, the initiation of the Phase 1 trial for R4996/MEM 63908 triggers a $2.0 million milestone payment from Roche.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia and depression. For additional information, please visit our website at http://www.memorypharma.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or Memory Pharmaceuticals' prospects, future financial position, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including the outcome of clinical trials of Memory Pharmaceuticals' drug candidates and whether they demonstrate these candidates' safety and effectiveness; the risks and uncertainties associated with: obtaining additional financing to support Memory Pharmaceuticals' R&D and clinical activities and operations; obtaining regulatory approvals to conduct clinical trials and to commercialize Memory Pharmaceuticals' drug candidates; Memory Pharmaceuticals' ability to enter into and maintain collaborations with third parties for its drug development programs; Memory Pharmaceuticals' dependence on its collaborations and its license relationships; achieving milestones under Memory Pharmaceuticals' collaborations; Memory Pharmaceuticals' dependence on preclinical and clinical investigators, preclinical an
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) today announced ... Firm of the Year by the Tech Council of ... TCM,s 25 th Annual Tech Awards Celebration held in ... recognizes the leaders and innovators in the technology and life ... surrounding regions. "We are deeply honored to ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... Annual  Healthcare Conference on Thursday, May 30, 2013, at ... beginning at 9:20 a.m. Eastern Daylight Time. Arvind ... will present at the conference. Live audio of the presentation ... www.amgen.com , under Investors. A replay of the webcast ...
(Date:5/23/2013)... May 23, 2013 Hearing health affects a man,s ... and remain socially and professionally engaged, he should address any ... message that the Better Hearing Institute (BHI) is ... National Men,s Health Week , which leads up to and ... from June 10 through June 16. To ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
(Date:5/24/2013)... With today’s levels of weight gain and obesity ... the causes of weight gain and how to lose weight ... of weight gain and treatments that will help patients lose ... by the Child Study Center at NYU Langone Medical Center ... ADHD and the soring rates of obesity later in life. ...
(Date:5/24/2013)... May 24, 2013 Today marks the ... online Itinerary Builder. , The redesigned and enhanced ... unique vacation itineraries on their computer or mobile device ... The interactive tool allows users to fill in their ... through and select their choice of vacation packages, accommodations, ...
(Date:5/24/2013)... CA (PRWEB) May 24, 2013 ... today of the latest update involving allegations that ... Zmax SR (azithromycin) can allegedly cause potentially ... Company reported on May 17, 2013* that Health ... Administration in warning that Zithromax can cause abnormal ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Scott Ryan ... brother, Troy Tischler, lose 200 lbs. of fat in ... Tischler teach his younger brother the importance of exercising. ... diet. By sticking to these 7 rules of healthy ... loss goals can be accomplished. , 1.    Find a distraction ...
(Date:5/24/2013)... Psoriasis treatment cream has been released online for ... registered company is now offering its natural solution to ... infected skin. , Dermasis has launched its new psoriasis ... cream is designed to offer immediate relief to those ... red skin often caused by psoriasis outbreaks. This new ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Help Patients with Weight Gain Linked to Childhood ADHD Lose Weight Fast 2Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2
... , WASHINGTON, July 22 The ... in the new book, Rethinking Responsibility: Reflections on Sex ... Teen and Unplanned Pregnancy, a nonprofit, nonpartisan organization, the volume includes ... , , , ...
... NEW YORK and SAN FRANCISCO, July 22 WeissComm ... Weiss , who was recently named an "Emerging Power Player" by ... the inaugural CLIO Healthcare Awards . The awards honor creative ... , About the CLIO Healthcare Awards and Entry ...
... HOUSTON, July 22 Service Corporation International (NYSE: SCI ) ... the second quarter 2009 on Wednesday, August 5, 2009, after the market ... Thursday, August 6, 2009. Details of the conference call are as ... Service Corporation International Second Quarter 2009 Earnings Conference Call , ...
... Proteus syndrome is a complex disorder associated with ... and unregulated adipose tissue. The overgrowth seen in ... Patients with Proteus syndrome require repeated treatment for ... period. Aggressive treatment may cause severe functional and ...
... , BINGHAM FARMS, Mich., July 22 ... as the new Director of Strategic Partnerships. Terrisca comes to ... Lives Save Dollars (SLSD) initiative where she served most recently as ... with key regional, state, national and international organizations to advance the ...
... , , , ... Board: ACCP) announced today that Jeffrey B. Davis, President & CEO, ... the LifeTech Capital Group on Thursday, July 30, 2009 at 10:45 am EDT. ... Astoria Boca Beach Club in Boca Raton, Florida. , , ...
Cached Medicine News:Health News:National Leaders Examine Sex and Responsibility in New Book 2Health News:National Leaders Examine Sex and Responsibility in New Book 3Health News:WeissComm Group CEO Jim Weiss Appointed Founding Board Member and Judge of First-Ever CLIO Healthcare Awards 2Health News:WeissComm Group CEO Jim Weiss Appointed Founding Board Member and Judge of First-Ever CLIO Healthcare Awards 3Health News:Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call 2Health News:Terrisca Des Jardins, MHSA, joins my1HIE as Director of Strategic Partnerships 2Health News:Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock Conference 2
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
Sealing tape, slightly stiffer than Polyolefin tape....
Sealing tape featuring 3M adhesive technology. Compatible with DMSO. Good optical quality. Minimal autofluorescence....
Medicine Products: